The Journal of Clinical Endocrinology & Metabolism
Bremelanotide for female hypoactive sexual desire disorder
2019 · PMID 31042226
Kingsberg SA et al.
View source
Dermal Compound
Cyclic heptapeptide melanocortin receptor agonist studied in MC3R/MC4R binding and central nervous system signaling research.
Est. delivery Thu, Jul 30–Wed, Aug 5 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Compound information
Technical specifications for laboratory reference
Molecular profile
Cyclic heptapeptide melanocortin receptor agonist studied in MC3R/MC4R binding and central nervous system signaling research.
Storage requirements
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 14 days
Literature
Peer-reviewed research for laboratory background
The Journal of Clinical Endocrinology & Metabolism
2019 · PMID 31042226
Kingsberg SA et al.
View sourceCitations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.
Quality documentation
Third-party tested · batch-specific results
99.9%purity
Passed full QC panel
Batch COA PDF not linked yet for this variant. Email support@peptideclub.com or browse all COAs.